Evidence map›Paper›PMID 42158947›Full record

ReviewFrontiers in pharmacology2026

Response mechanism of hepatorenal metabolic barrier function to drugs and environmental poisons and intervention strategy of natural products.

Zhen Li, Yi Li, Junfeng Zhu, Zhiqiang Zheng, Wenqiang Xie, Che Xu

Abstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Pharmaceuticals (Basel, Switzerland) · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zhen LiYueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Yi LiYueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Junfeng ZhuYueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Zhiqiang ZhengYueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Wenqiang XieYueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Che XuYueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Liver and kidney, as the core metabolic detoxification organs of human body, rely on specific biofilm barrier and metabolic enzyme system to form metabolic barrier respectively. This metabolic barrier is the key defense line to resist the invasion of drugs and environmental poisons. There are significant differences in the structural function and toxic response mechanism of the metabolic barrier between the liver and kidney. This review explains the core composition and physiological function of the hepatorenal metabolic barriers respectively. It also systematically analyzes the specific mechanisms of toxic damage to these barriers. The core of liver injury is the destruction of hepatic sinus barrier, disorder of metabolic enzyme expression and bile excretion disorder. Renal injury focuses on glomerular filtration barrier injury, abnormal renal tubular transport function and renal interstitial inflammatory reaction. In this review, the specific protective value and intervention mechanism of natural products such as herbal components, single Chinese medicinal herbs and Chinese medicinal prescriptions on hepatorenal metabolic barrier damage were summarized. This provides targeted theoretical support for the development of hepatorenal protective drugs.

Indexed as

drug toxicantsenvironmental toxicantshepatic metabolic barrierintervention mechanismnatural productsrenal metabolic barrier

Identifiers

PMID42158947
PMCPMC13180869

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.